Aug 25, 2026 09:08AM
Aug 24, 2026 08:03AM
Aug 18, 2026 09:09AM
Aug 13, 2026 04:01PM
Aug 13, 2026 04:01PM
Aug 3, 2026 07:30AM
May 15, 2026 06:01AM ARS Pharmaceuticals, Inc. (SPRY) Misses Q1 EPS by 12c, Beats on Revenue
May 15, 2026 06:00AM
May 7, 2026 08:00AM
Mar 10, 2026 06:22AM
Mar 9, 2026 06:00AM
Feb 23, 2026 08:00AM
Nov 10, 2025 06:09AM
Nov 10, 2025 06:00AM ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
Nov 3, 2025 08:00AM
Aug 14, 2025 05:50AM
Aug 13, 2025 07:09AM
Aug 13, 2025 07:00AM
Aug 4, 2025 08:00AM
May 14, 2025 04:13PM
May 14, 2025 07:00AM ARS Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Progress in U.S. Commercial Launch of neffy® (epinephrine nasal spray)
May 5, 2025 08:00AM
May 2, 2025 08:00AM
Mar 31, 2025 06:19AM
Mar 24, 2025 05:24AM
Mar 20, 2025 10:06AM
Mar 20, 2025 07:00AM
Mar 3, 2025 04:35PM ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences
Jan 13, 2025 08:00AM
Nov 13, 2024 06:30AM
Nov 6, 2024 08:00AM
Aug 7, 2024 04:55AM
Aug 6, 2024 04:01PM
May 9, 2024 04:05PM
Mar 21, 2024 04:05PM ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Nov 9, 2023 06:37PM
Nov 9, 2023 04:00PM
Aug 10, 2023 04:00PM
May 15, 2023 09:00AM
May 15, 2023 09:00AM
Mar 23, 2023 04:01PM
Mar 23, 2023 04:01PM ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results

1,222,855 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All